Is the FDA certification process too complicated? Is the agency service a waste of money or a life-saving straw?

"Mr. Zhang's medical device company developed an innovative product, but due to the complex FDA certification process, it has been unable to enter the US market for a long time..." Such stories are every day. As the gold standard for global medical and health products, FDA certification is both a quality endorsement and a "roadblock" for countless enterprises. This article will reveal the core logic of agent export for FDA, providing a compliant and efficient overseas expansion path for small and medium-sized enterprises.

The FDA (U.S. Food and Drug Administration) certification system includes different paths such as 510(k) and PMA, involving dozens of requirements such as technical documents, clinical data, and quality management systems. For small and medium-sized enterprises with limited resources:

• The average time for self-application is 18 - 24 months, while an agency can shorten it to 6 - 12 months
• A professional team can avoid 87% of common document rejection problems
• Agencies like ZST provide full-process custody from pre-review to on-site inspection

Ms. Li's in vitro diagnostic reagent completed both EU CE and US FDA dual certifications in just 9 months through agency services.

1. Historical successful cases: Require the provision of at least 3 certification records of similar products, paying special attention to the differences between the 510(k) and De Novo paths.

2. Localization capabilities: A local US compliance team can quickly respond to FDA surprise inspections, and time zone issues may lead to delays in key communications.

3. Value-added service network: Including but not limited to derivative needs such as legal counsel, insurance connection, and logistics clearance. ZST's "one-stop overseas expansion solution" can reduce the comprehensive cost by 30%.

• Beware of the "100% pass rate" promotion. The FDA has never authorized any agency to make such guarantees
• The contract must clearly state phased payment terms, and it is recommended that the down payment ratio does not exceed 30%
• Require a weekly bilingual progress report, and for key nodes such as Q-submission, the original FDA email should be provided

In a certain flight inspection, the FDA issued a warning letter due to the lack of temperature control records at the subcontracting factory, but the emergency plan deployed in advance by the agency avoided the risk of product delisting.

Since 2023, the FDA has started to pilot the eSTAR electronic submission system. Leading agencies have developed AI document self-check tools, which can reduce the error rate of technical documents by 62%. It is recommended that enterprises give priority to service providers with an intelligent pre-review system, which will become the dividing line for the next generation of agency services.

As the global medical market continues to expand, agent export for FDA is not only a compliance choice but also a strategic investment. Have you ever encountered certification problems? Welcome to share your experiences, and let's jointly explore more possibilities for Made in China to go global.